Page last updated: 2024-12-07

isopelletierine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isopelletierine: RN given refers to cpd without isomeric designation; synonym pelletierine refers to (-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92987
CHEMBL ID2448876
CHEBI ID7952
SCHEMBL ID156790
MeSH IDM0051837

Synonyms (58)

Synonym
DIVK1C_006427
KBIO1_001371
SDCCGMLS-0066638.P001
SPECTRUM_001293
dl-pelletierine
1-(2-piperidinyl)-2-propanone
isopelletierine
8-methylnorlobelone
(+-)1-(2-piperidinyl)-2-propanone
isopunicine
pelletierine, (+-)-
2-propanone, 1-(2-piperidinyl)-, (+-)
isopelletierin
SPECTRUM5_001803
NCGC00178456-01
BSPBIO_002811
C06182
pelletierine
4396-01-4
KBIO2_006909
KBIOSS_001773
KBIO3_002031
KBIOGR_001733
KBIO2_004341
KBIO2_001773
SPECPLUS_000331
SPECTRUM3_001026
SPBIO_000681
SPECTRUM4_001157
SPECTRUM2_000651
539-00-4
1-piperidin-2-ylpropan-2-one
AKOS006281199
unii-npl21m0a40
einecs 224-523-0
npl21m0a40 ,
chebi:7952 ,
CHEMBL2448876
isopelletierine [mi]
(+/-)-isopelletierine
(+/-)-pelletierine
pelletierine, (+/-)-
2-propanone, 1-(2-piperidinyl)-
1-piperidin-2-ylacetone
SCHEMBL156790
1-(2-piperidinyl)acetone #
JEIZLWNUBXHADF-UHFFFAOYSA-N
2-acetonylpiperidinepunicineisopelletierine, (.+/-.)-pelletierine
pelletierin
(+-)-pelletierine
(+-)-1-(2-piperidinyl)-2-propanone
2-propanone, 1-(2-piperidinyl)-, (+-) (9ci)
pelletierine (isopelletierine)
Q27107635
DTXSID00863036
1-(piperidin-2-yl)propan-2-one
SB42828
EN300-99794
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
citraconoyl group
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID781327pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 20072014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (43.75)18.7374
1990's0 (0.00)18.2507
2000's1 (6.25)29.6817
2010's7 (43.75)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.55 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]